Primary Category:
Cancer Control and Prevention Protocols
Disease Category:
Colon, Gastrointestinal, Rectal
Status:
Open
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
Eligible for screening study DCP 001
A221805-Substudy SI1 is closed to accrual, effective September 15, 2022, at 4:30pm ET
NCT#04137107
